CVX-343, a Long-Acting FGF21 CovX-Body, Demonstrates Prolonged Anti-Diabetic Efficacy in Diabetic Mouse Models
Jie Huang, Paul Rolzin,Trina F. Osothprarop,Tetsuya Ishino,Joe Wiese, Kelsey Retting,Joselyn Del Rosario,Lingna Li, Calvin Vu,Marla J. Matin, Zemeda W. Ainekulu, Arvind Kinhikar,Moorthy Palanki, Bernard Huyghe, Bernard N. Violand, Rory F. Finn,Gary Woodnutt,Rodney W. Lappe,Nancy Levin DIABETES（2011）
AI 理解论文
溯源树
样例
